Skip to content

Evaluation of Prophylactic Endotracheal Intubation

Evaluation of Prophylactic Endotracheal Intubation in the Patients With Upper Gastrointestinal Bleeding Undergoing Urgent Endoscopy: A Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03716466
Enrollment
65
Registered
2018-10-23
Start date
2018-11-11
Completion date
2021-07-09
Last updated
2022-05-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Bleeding, Intubation;Difficult

Brief summary

Upper gastrointestinal (GI) bleeding is defined as patients who either presented with hematemesis or presented with melena along with evidence of hemodynamic compromise. These patients have risk of aspiration of blood along with gastric content. The mortality rate can be 15% to 20% in the cases with variceal bleeding. From a practical standpoint, it is widely accepted that the best way to secure an airway during upper GI bleeding is prophylactic endotracheal intubation (PEI). The aim of this study is to determine the incidence of complications among critically ill patients with upper GI bleeding and received urgent endoscopy.

Detailed description

This is a prospective observational study. After IRB approval, consecutive patient with upper GI bleeding and undergoing urgent endoscopy will be enrolled to the study over 24 months period. Data pull will be requested from Parkland Office of Research Administration (ORA) regarding eligible subjects and protocol requiring data elements. The data pull will be requested at the end of the 24 months-period. Primary endpoint: The incidence of cardiovascular unplanned event within 48 hours of the upper gastrointestinal endoscopy procedure. Secondary end points: The incidence of pulmonary unplanned event within 48 hours of the upper gastrointestinal endoscopy procedure.

Interventions

OTHERNo airway intervention

Subjects without prophylactic endotracheal intubation during upper gastrointestinal endoscopy procedure

OTHEREndotracheal intubation

Subjects will receive prophylactic endotracheal intubation for upper gastrointestinal endoscopy procedure

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years

Inclusion criteria

* Age 18 years and older * Presence of upper gastrointestinal bleeding either presented with hematemesis or melena along with evidence of hemodynamic compromise. * Received procedural (conscious) sedation * Undergoing urgent upper gastrointestinal endoscopy procedures

Exclusion criteria

* Intubation other than airway protection * Prior tracheostomy before onset of gastrointestinal bleeding * Subjects intubated before transfer to gastrointestinal suite * Subjects without hemodynamic instability * Subjects with a diagnosis of pneumonia, acute respiratory distress syndrome, myocardial infarction, pulmonary edema, arrhythmia, or cardiac arrest before endoscopy * Endoscopy done for other than upper gastrointestinal bleeding * Pregnant subjects

Design outcomes

Primary

MeasureTime frameDescription
Cardiovascular unplanned eventPostoperative up to 48 hoursThe number of cardiovascular unplanned event after upper gastrointestinal endoscopy, up to 48 hours

Secondary

MeasureTime frameDescription
Pulmonary unplanned eventPostoperative up to 48 hoursThe number of pulmonary unplanned event after upper gastrointestinal endoscopy, up to 48 hours.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026